265 research outputs found
Oral administration of sitagliptin activates CREB and is neuroprotective in murine model of brain trauma
Introduction: Traumatic brain injury is a major cause of mortality and morbidity. We have previously shown that the injectable glucagon-like peptide-1 (GLP-1) analog, liraglutide, significantly improved the outcome in mice after severe traumatic brain injury (TBI). In this study we are interested in the effects of oral treatment of a different class of GLP-1 based therapy, dipeptidyl peptidase IV (DPP-IV) inhibition on mice after TBI. DPP-IV inhibitors reduce the degradation of endogenous GLP-1 and extend circulation of this protective peptide in the bloodstream. This class has yet to be investigated as a potential therapy for TBI. Methods: Mice were administrated once-daily 50 mg/kg of sitagliptin in a Nutella® ball or Nutella® alone throughout the study, beginning 2 days before severe trauma was induced with a stereotactic cryo-lesion. At 2 days post trauma, lesion size was determined. Brains were isolated for immunoblotting for assessment of selected biomarkers for pathology and protection. Results: Sitagliptin treatment reduced lesion size at day 2 post-injury by ~28% (p < 0.05). Calpain-driven necrotic tone was reduced ~2-fold in sitagliptin-treated brains (p < 0.001) and activation of the protective cAMP-response element binding protein (CREB) system was significantly more pronounced (~1.5-fold, p < 0.05). The CREB-regulated, mitochondrial antioxidant protein manganese superoxide dismutase (MnSOD) was increased in sitagliptin-treated mice (p < 0.05). Conversely, apoptotic tone (alpha-spectrin fragmentation, Bcl-2 levels) and the neuroinflammatory markers IL-6, and Iba-1 were not affected by treatment. Conclusions: This study shows, for the first time, that DPP-IV inhibition ameliorates both anatomical and biochemical consequences of TBI and activates CREB in the brain. Moreover, this work supports previous studies suggesting that the effect of GLP-1 analogs in models of brain damage relates to GLP-1 receptor stimulation in a dose-dependent manner
Extraktion technischer Prinzipe und Bewegungssimulation für eine verbesserte technische Dokumentation
Analysis of clogging in constructed wetlands using magnetic resonance
In this work we demonstrate the potential of permanent magnet based magnetic resonance sensors to monitor and assess the extent of pore clogging in water filtration systems. The performance of the sensor was tested on artificially clogged gravel substrates and on gravel bed samples from constructed wetlands used to treat wastewater. Data indicate that the spin lattice relaxation time is linearly related to the hydraulic conductivity in such systems. In addition, within biologically active filters we demonstrate the ability to determine the relative ratio of biomass to abiotic solids, a measurement which is not possible using alternative techniques
Det samarbejdende godstransportsystem
Det samarbejdende godstransportssystem halter i Danmark sammenlignet med de lande i EU som vi normalt sammenligner os med. Transitgods er stærkt voksende og også Infrastrukturkommissionens rapport har tydeligt vist de markante udfordringer transportsystemet står over for
Renal Function but Not Asymmetric Dimethylarginine Is Independently Associated with Retinopathy in Type 2 Diabetes
Background. Asymmetric dimethylarginine (ADMA) is associated with macrovascular disease and possibly with microangiopathy in type 2 diabetes (T2DM). We tested the hypothesis that ADMA is related to diabetic retinopathy (DR) independently of macrovascular disease. Methods. This cross-sectional study included 127 T2DM patients selected to achieve equal distributions of patients with and without macrovascular disease in the groups with and without DR. Results. Patients with DR had increased ADMA, longer diabetes duration, and reduced glomerular filtration rate (GFR). ADMA correlated with GFR (ρ = -0.35; P < .001), diabetes duration (ρ = 0.19; P = .048), and age (ρ = 0.19; P = .033). Logistic regression analysis revealed an association of ADMA with DR. After adjustment for macrovascular disease, this association remained significant (OR 1.48; 95% CI: 1.02–2.15; P = .039). Inclusion of GFR and T2DM duration into the model abolished this significant relationship. GFR remained the only independent predictor for DR. A 10 mL/min/1.73 m2 GFR decrease was associated with DR in a multivariate model (OR 1.30; 95% CI: 1.08–1.56; P = .006). Conclusions. These findings indicate an association between ADMA and DR in T2DM independent of macrovascular disease. This relationship is modified by GFR, the only parameter significantly related to DR in multivariate analysis
Glucagon-like peptide-1 analog, Liraglutide, delays onset of experimental autoimmune encephalitis in Lewis rats
AbstractIntroduction: Recent findings indicate that metabolic disturbances are involved in multiple sclerosis (MS) pathology and influence the susceptibility to treatment, directing attention towards anti-diabetic drugs such as metformin and pioglitazone. Liraglutide, a drug of the glucagon-like peptide-1 (GLP-1) family, is also anti-diabetic and weight-reducing and is moreover, directly neuroprotective and anti-inflammatory in a broad spectrum of experimental models of brain disease. In this study we investigate the potential for this FDA-approved drug, liraglutide, as a treatment for MS by utilizing the experimental model, experimental autoimmune encephalitis (EAE).Methods: EAE was induced in 30 female Lewis rats that subsequently received twice-daily liraglutide (200 µg/kg s.c.) or saline. Healthy controls were included (saline, n=6, liraglutide, n=7). Clinical score and weight were assessed daily by blinded observers. Animals were killed at peak disease severity (day 11) or if exceeding humane endpoint (clinical score ≥4). Protein levels of manganese superoxide dismutase (MnSOD), amyloid precursor protein (APP, and glial fibrillary acidic protein (GFAP) were determined.Results: Liraglutide treatment delayed disease onset (group clinical score significantly >0) by two days and markedly reduced disease severity (median clinical score 2 vs. 5; p=0.0003). Fourteen of 15 (93%) of vehicle-treated rats reached the humane endpoint (clinical score ≥4) by day 11 compared to 5 of 15 (33%) of liraglutide-treated rats (p=0.0004). Liraglutide substantially increased the mitochondrial antioxidant MnSOD (p<0.01) and reduced the neurodegenerative marker APP (p=0.036) in the brain. GFAP levels were not significantly changed with drug treatment (p=0.09)Conclusion: We demonstrate, for the first time, that liraglutide treatment delays onset of EAE in Lewis rats and is associated with improved protective capacity against oxidative stress. These data suggest GLP-1 receptor agonists should be investigated further as a potential therapy for MS.Keywords: GLP-1, EAE, Multiple Sclerosis, liraglutide, MS, MnSOD, AP
High-Fat Diet Induces Unexpected Fatal Uterine Infections in Mice with aP2 -Cre-mediated Deletion of Estrogen Receptor Alpha
Estrogen receptor alpha (ERα) is a major regulator of metabolic processes in
obesity. In this study we aimed to define the relevance of adipose tissue ERα
during high-fat diet (HFD)-induced obesity using female aP2-Cre−/+/ERαfl/fl
mice (atERαKO). HFD did not affect body weight or glucose metabolism in
atERαKO- compared to control mice. Surprisingly, HFD feeding markedly
increased mortality in atERαKO mice associated with a destructive bacterial
infection of the uterus driven by commensal microbes, an alteration likely
explaining the absence of a metabolic phenotype in HFD-fed atERαKO mice. In
order to identify a mechanism of the exaggerated uterine infection in HFD-fed
atERαKO mice, a marked reduction of uterine M2-macrophages was detected, a
cell type relevant for anti-microbial defence. In parallel, atERαKO mice
exhibited elevated circulating estradiol (E2) acting on E2-responsive
tissue/cells such as macrophages. Accompanying cell culture experiments showed
that despite E2 co-administration stearic acid (C18:0), a fatty acid elevated
in plasma from HFD-fed atERαKO mice, blocks M2-polarization, a process known
to be enhanced by E2. In this study we demonstrate an unexpected phenotype in
HFD-fed atERαKO involving severe uterine bacterial infections likely resulting
from a previously unknown negative interference between dietary FAs and ERα-
signaling during anti-microbial defence
- …